• Contractor Notice: Expiry of SSP037 Estraderm MX® 50mcg patches

    The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estraderm MX® 50mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP037 Estraderm MX® 50mcg patches expires at 23.59pm on Wednesday 23 November 2022. After this date, any prescriptions for Estraderm MX® 50mcg

    Read more
  • Reminder: Completing patient declarations for age exempt patients

    PSNC’s Pricing Audit Team have noted seeing an increase in unsigned patient declarations for patients who are age exempt where the date of birth is handwritten. Pharmacy teams are reminded that where the date of birth is handwritten the patient declaration on the reverse of the prescription MUST be completed in full, i.e. exemption box

    Read more
  • PQS: Assessment framework now available

    Community pharmacy contractors can now access the assessment framework on PharmOutcomes for the 2022/23 Pharmacy Quality Scheme (PQS). This is available free of charge to all contractors. The assessment framework allows contractors and their teams to track their progress with achieving the gateway and quality criteria/domains of the PQS. Once a contractor has logged into PharmOutcomes,

    Read more
  • November 2022 Price Concessions 2nd Update

    The Department of Health and Social Care (DHSC) has today (22/11/2022) granted the following list of price concessions for November 2022: Drug Pack size Price concession Alendronic acid 70mg tablets 4 £5.36 Amisulpride 100mg tablets 60 £20.29 Amisulpride 200mg tablets 60 £33.92 Amisulpride 50mg tablets 60 £13.09 Amorolfine 5% medicated nail lacquer 5 £7.34 Aripiprazole

    Read more
  • Help improve the Electronic Prescription Service

    NHS Digital is asking community pharmacy team members to share their experience of using the Electronic Prescription Service (EPS) by volunteering to take part with a short EPS interview. Such user feedback is essential to informing the future development of the system ahead of the planned launch of the next generation of EPS. PSNC and

    Read more
  • MHRA – Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited)

    Class 4 Medicines Defect Information: Hyoscine Butylbromide 20 mg film-coated tablets (Morningside Healthcare Limited) Drug alert number: EL (22)A/48 Date issued: 21 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Hyoscine Butylbromide 20 mg film-coated tablets, PL 20117/0349 Batch Number Expiry Date Pack

    Read more
  • November 2022 Price Concessions 1st Update

    The Department of Health and Social Care (DHSC) has today (18/11/2022) granted the following initial list of price concessions for November 2022: Drug Pack size Price concession Amoxicillin 250mg/5ml oral suspension 100 £2.69 Amoxicillin 250mg/5ml oral suspension sugar free 100 £2.69 Benzydamine 0.15% mouthwash sugar free 300 £4.65 Bisacodyl 5mg gastro-resistant tablets 60 £4.99 Bisoprolol

    Read more
  • Autumn Statement: PSNC calls for investment in pharmacies

    The Chancellor of the Exchequer, Jeremy Hunt, has today (17th November) given his Autumn Statement, setting out Government spending plans. The Statement promises that the NHS budget will be increased in each of the next two years by £3.3bn, going some way towards meeting the request of NHS CEO Amanda Pritchard. But the Chancellor made

    Read more
  • PSNC hosts well attended parliamentary event

    On Tuesday 15th November PSNC hosted a parliamentary drop-in event for MPs and peers. The event lasted for two hours, during which MPs had the opportunity to drop-in and have their blood pressure measured by a pharmacists with experience of working on the front-line and were briefed on the urgent need for action to address

    Read more
  • Two SSPs issued for Estraderm® MX 50mcg and 75mcg patches

    In response to a significant ongoing disruption to the supply of Estraderm MX® 50mcg and 75mcg patches, two new Serious Shortage Protocols (SSPs) have been issued by the Department of Health and Social Care (DHSC). Effective 15 November 2022, SSP037 and SSP038 provides for the following: SSP037 – for every Estraderm MX® 50mcg  patch originally prescribed, one

    Read more